Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Research Coverage on Small and Micro-Cap Companies

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Equity Bottom-Up

<ul><li>Spectral AI is developing an AI-guided predictive medical device that employs multispectral imaging (MSI) to estimate a wound's capacity to heal.</li><li>The company is pursuing indications in burn and diabetic foot ulcers (DFUs) with the former receiving support from BARDA & other government agencies.</li><li>Spectral is distinguished by its combination of MSI and AI to improve diagnoses.</li></ul>

Spectral AI is developing an AI-guided predictive medical device that employs multispectral imaging (MSI) to estimate a wound's capacity to heal.The company is pursuing indications in burn and diabetic foot ulcers (DFUs) with the former receiving support from BARDA & other government agencies.Spectral is distinguished by its combination of MSI and AI to improve diagnoses.

<ul>
<li>Spectral AI is developing an AI-guided predictive medical device that employs multispectral imaging (MSI) to estimate a wound's capacity to heal.</li>
<li>The company is pursuing indications in burn and diabetic foot ulcers (DFUs) with the former receiving support from BARDA &amp; other government agencies.</li>
<li>Spectral is distinguished by its combination of MSI and AI to improve diagnoses.</li>
</ul>


Spectral AI is developing an AI-guided predictive medical device that employs multispectral imaging (MSI) to estimate a wound's capacity to heal.
The company is pursuing indications in burn and diabetic foot ulcers (DFUs) with the former receiving support from BARDA &amp; other government agencies.
Spectral is distinguished by its combination of MSI and AI to improve diagnoses.


Spectral AI, Inc - MDAI: Management Changes

Independent Research, SPACs, SPAC Track

SPAC Track

Independent Research, SPACs

Equity Capital Markets

Endurance Acquisition Corp / Equity Capital Markets

<ul><li>Endurance Acquisition Corp. (EDNC) &amp; SatixFy (Valuation: $632M EV)</li><li>AMCI Acquisition Corp. II (AMCI) &amp; LanzaTech NZ (Valuation: $1.82B EV)</li><li>Rosecliff Acquisition Corp (RCLF) and Gett mutually agree to terminate their merger due to current market conditions</li></ul>

Endurance Acquisition Corp. (EDNC) &amp; SatixFy (Valuation: $632M EV)AMCI Acquisition Corp. II (AMCI) &amp; LanzaTech NZ (Valuation: $1.82B EV)Rosecliff Acquisition Corp (RCLF) and Gett mutually agree to terminate their merger due to current market conditions

United States

Spectral AI, Inc. operates as a predictive AI company. The Company focuses on medical diagnostics for faster and more accurate treatment decisions in wound care for burn, DFU, and future clinical applications. Spectral AI serves customers in the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Spectral AI (MDAI US)

MDAI: Burn Study Topline Data

Spectral AI is developing an AI-guided predictive medical device that employs multispectral imaging (MSI) to estimate a wound's capacity to...

Zacks Small Cap Research

MDAI: Pivotal Data Analysis Complete

Spectral AI is developing an AI-guided predictive medical device that employs multispectral imaging (MSI) to estimate a wound's capacity to...

Zacks Small Cap Research

MDAI: December Topline Expected

Spectral AI is developing an AI-guided predictive medical device that employs multispectral imaging (MSI) to estimate a wound's capacity to...

Zacks Small Cap Research

Spectral AI, Inc - MDAI: Management Changes

Spectral AI is developing an AI-guided predictive medical device that employs multispectral imaging (MSI) to estimate a wound's capacity to heal.

Zacks Small Cap Research

The SPAC Week in Review

Endurance Acquisition Corp. (EDNC) & SatixFy (Valuation: $632M EV). AMCI Acquisition Corp. II (AMCI) & LanzaTech NZ (Valuation: $1.82B EV)

SPAC Track

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)